Exact Mass: 242.1577332
Exact Mass Matches: 242.1577332
Found 500 metabolites which its exact mass value is equals to given mass value 242.1577332,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1,5-Diphenylcarbazide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents KEIO_ID D166; [MS2] KO009100 KEIO_ID D166
Falcarinone
Isolated from Sium sisarum (skirret). Falcarinone is found in many foods, some of which are parsley, green vegetables, caraway, and coffee and coffee products. Falcarinone is found in caraway. Falcarinone is isolated from Sium sisarum (skirret).
Selagine
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
4,4a,5,6,7,8-Hexahydro-6-(p-hydroxyphenyl)-2(3H)-naphthalenone
6-Ketomyristic acid
6-Ketomyristic acid is found in milk and milk products. 6-Ketomyristic acid is a trace constituent of milk fa Trace constituent of milk fat. 6-Ketomyristic acid is found in milk and milk products.
(Z,Z)-2,9,16-Heptadecatriene-4,6-diyn-8-ol
(Z,Z)-2,9,16-Heptadecatriene-4,6-diyn-8-ol is found in green vegetables. (Z,Z)-2,9,16-Heptadecatriene-4,6-diyn-8-ol is isolated from fresh roots of Silybum marianum (milk thistle Isolated from fresh roots of Silybum marianum (milk thistle). (Z,Z)-2,9,16-Heptadecatriene-4,6-diyn-8-ol is found in green vegetables.
(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one
(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is found in herbs and spices. (3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is a constituent of New Zealand thyme honey (Thymus vulgaris). Constituent of New Zealand thyme honey (Thymus vulgaris). (3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one is found in herbs and spices.
3-Oxotetradecanoic acid
3-Oxo-tetradecanoic acid is an intermediate in fatty acid biosynthesis. Specifically, 3-Oxo-tetradecanoic acid is converted from Malonic acid via three enzymes; 3-oxoacyl-[acyl-carrier-protein] synthase, fatty-acid Synthase and beta-ketoacyl -acyl-carrier-protein synthase II. (EC:2.3.1.41, E.C: 2.3.1.85, 2.3.1.179). In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation. [HMDB] 3-Oxo-tetradecanoic acid is an intermediate in fatty acid biosynthesis. Specifically, 3-Oxo-tetradecanoic acid is converted from Malonic acid via three enzymes; 3-oxoacyl-[acyl-carrier-protein] synthase, fatty-acid Synthase and beta-ketoacyl -acyl-carrier-protein synthase II. (EC:2.3.1.41, E.C: 2.3.1.85, 2.3.1.179). In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation.
2-Carboxy-4-dodecanolide
2-Carboxy-4-dodecanolide is found in milk and milk products. 2-Carboxy-4-dodecanolide is a possible latent butter aroma compoun
L-Menthyl (R,S)-3-hydroxybutyrate
L-Menthyl (R,S)-3-hydroxybutyrate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
(-)-Huperzine A (HupA)
2-(Ethoxymethyl)-1h-Imidazo[4,5-C]quinolin-4-Amine
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-hydroxy-1-methylbutyl)-
Huperzine_A
LSM-1581 is a quinolone. (+/-)-Huperzine A is a natural product found in Streptomyces coelicoflavus and Huperzia with data available. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors Huperzine A is a sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimers disease. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a neuroprotective agent, a plant metabolite and a nootropic agent. It is a sesquiterpene alkaloid, a pyridone, a primary amino compound and an organic heterotricyclic compound. It is a conjugate base of a huperzine A(1+). Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being investigated as a possible treatment for diseases characterized by neurodegeneration – particularly Alzheimer’s disease. Huperzine A is a natural product found in Phlegmariurus varius, Phlegmariurus tetrastichus, and other organisms with data available. A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimers disease. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
(4R)-4-(Hydroxymethyl)-3-(6-methylheptanoyl)dihydro-2(3H)-furanone
Methyl 5-methyl-8-isopropyl-2-naphthalenecarboxylate
[1R-(1alpha,2beta,3beta)]-3-Hydroxy-2-(hydroxymethyl)-3-methyl-gamma-methylene-cyclopentanebutanoic acid methyl ester
Huperzine A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents Origin: Plant; SubCategory_DNP: Sesquiterpenoids D020011 - Protective Agents D004791 - Enzyme Inhibitors (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
1-deoxooenanthotoxin|all-trans-Heptadecatrien-(2.8.10)-diin-(4.6)-ol-(14)|heptadeca-7t,9t,15t-triene-11,13-diyn-4-ol
4,N2,N6-trimethyl-1H-cyclohepta[1,2-d;4,5-d]diimidazole-2,6-diamine|Parazoanthoxanthin
(-)-butane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate
heptadeca-7t,9t-diene-11,13-diyn-4-one|trans,trans-Heptadecadien-(8.10)-diin-(4.6)-on-(14)
5-hydroxy-hexadeca-6t,8t,14t-triene-10,12-diynal cyclohemiacetal|6-undeca-1,3t,9t-triene-5,7-diyn-t-yl-tetrahydro-pyran-2-ol
(all-E)-form-16-Hydroxy-2,8,10-hexadecatriene-4,6-diynal|16-hydroxy-hexadeca-2E,8E,10E-trien-4,6-diyn-1-al
trans-6-hydroxymethyl-3-methyl-7-oxo-undecan-4-olide
Me ether-(2R*,5R*,1E,3E,9Z)-form-Tetrahydro-5-(1,3,9-undecatriene-5,7-diynyl)-2-furanol,
(1,8E,10E)-heptadecatriene-4,6-diyn-3-ol|(all-E)-1,8,10-Heptadecatriene-4,6-diyn-3-ol|heptadeca-1,8t,10t-triene-4,6-diyn-3-ol|Heptadecatrien-(1,8t,10t)-diin-(4,6)-ol-(3)|trans-trans-Heptadecatrien-(1.8.10)-diin-(4.6)-ol-(3)
(2E,8E,10E)-heptadeca-2,8,10-triene-4,6-diyn-1-ol|14-deoxooenanthotoxin|2,8,10-Heptadecatriene-4,6-diyn-1-ol|Bupleurynol|Heptadeca-2t,8t,10t-trien-4,6-diin-1-ol|heptadeca-2t,8t,10t-triene-4,6-diyn-1-ol|Oenanthetol|trans-bupleurynol
1,4,N8-trimethyl-1H-cyclohepta[1,2-d;3,4-d]diimidazole-2,8-diamine
(-)-(1S,2S,2R)-4-(2-Hydroxy-2,6,6-trimethylcyclohexyl)-2-methylbutanoic acid
(E,E)-1,9,15-Heptadecatriene-11,13-diyn-8-ol|heptadeca-2E,8E,16-triene-4,6-diyne-10-ol
trans-8,9-dihydroxy-3-methyldodec-cis-6-en-4-olide
Ac-6-Tetrdecene-8,10,12-triyn-3-ol|artemisia acetate
(1S,2R,2S,6S)-4-(2-Hydroxy-2,6-dimethyl-5-oxocyclohexyl)-2-methylbutanoic acid
1-Acetoxy-tetradeca-4,6,12-trien-8,10-diin|1-Acetoxy-tetradeca-4t,6t,12t-trien-8,10-diin|1-Acetoxy-tetradecatrien-(4,6,12)-diin-(8,10)|14-acetoxy-tetradeca-2t,8t,10t-triene-4,6-diyne|Ac-4,6,12-Tetradecatriene-8,10-diyn-1-ol,
(3R,4R,5S,6R)-4-hydroxy-6-((R,E)-3-hydroxy-3-methylpent-1-en-1-yl)-3,5-dimethyltetrahydro-2H-pyran-2-one|3-hydroxy-8-((E)-10-hydroxy-10-methylpentenyl)-2,4-dimethyltetrahydropyranone
cis-cis-Heptadeca-2,9,16-trien-4,6-diin-1-ol|heptadeca-2c,9c,16-triene-4,6-diyn-1-ol
(all-E)-6,8,14-Hexadecatriene-10,12-diyn-1-ol|6,8,14-Hexadecatriene-10,12-diyn-1-ol
(all-E)-8,10,14,16-Heptadecatetraen-6-yn-3-one|heptadeca-8t,10t,14t,16-tetraen-6-yn-3-one|Heptadecatetraen-(1.3-trans.7-trans.9-trans)-in-(11)-on-(15)
8-N-desmethylparagracine|Dimethuylpseudozoanthoxanthin A
(Z)-9,16-Heptadecadiene-4,6-diyn-8-one|heptadeca-9c,16-diene-4,6-diyn-8-one
3-isopropyl-9a-methyl-1,2,4a,9a-tetrahydroxanthene
S-(trans-3-Oxoundec-4-enyl)thioacetat|S-Ac-1-Mercapto-4-undecen-3-one
heptadeca-9t,15t-diene-11,13-diyn-4-one|trans,trans-Heptadecadien-(2.8)-diin-(4.6)-on-(14)
6-methoxy-2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene
(4aS),( 10bS)-7-amino-3,4,4a,5,6,10b-hexahydro-2,4-dimethyl-6-oxobenzo[f]quinoline
2,5,6-Trihydroxy-7-megastigmen-9-one|trihydroxy-beta-ionone
2-methylpropane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate
(6E,8E,10E)-1,6,8,10-Heptadecatetraen-4-yn-3-one|(6E,8E,10E)-heptadeca-1,6,8,10-tetraen-4-yn-3-one|heptadeca-1,6t,8t,10t-tetraen-4-yn-3-one
Heptadeca-2c,9c-dien-4,6-diin-1-al|heptadeca-2c,9c-diene-4,6-diynal|Heptadeca-2c.9c-dien-4.6-diin-1-al
(all-E)-4,8,10,14,16-Heptadecapentaen-6-yn-3-ol|heptadeca-4t,8t,10t,14t,16-pentaen-6-yn-3-ol|Heptadecapentaen-(1.3trans.7trans.9trans.13trans)-in-(11)-ol-(15)
(7E,9E)-1,7,9-Heptadecatriene-11,13-diyn-6-ol|heptadeca-1,7t,9t-triene-11,13-diyn-6-ol
Dihydrolapachenole
Dihydrolapachenole is a naturally occurring quinone[1].
HuperzineA
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 0.361 D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 0.348 (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
MLS001074335-01!(3,5-dimethyl-1-adamantyl)amine nitrate
C13H22O4_6-Oxabicyclo[3.2.1]octane-3,8-diol, 8-[(1E)-3-hydroxy-1-buten-1-yl]-1,5-dimethyl
C13H22O4_(3E)-4-(1,2,4-Trihydroxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one
Huperzin A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2242 D020011 - Protective Agents D004791 - Enzyme Inhibitors INTERNAL_ID 2242; CONFIDENCE Reference Standard (Level 1) (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5]. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
(3aS)-1-methyl-3a-(3-methylbut-2-en-1-yl)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole
14-METHOXY-4,4-BISNOR-4,8,11,13-PODOCARPATETRAEN-3-ONE
(3S,5R,6R,7E)-3,5,6-Trihydroxy-7-megastigmen-9-one
Ieodomycin A
A natural product found in Bacillus species.
N-(TERT-BUTYL)-3-(2-HYDROXYPROPAN-2-YL)-5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOLE-1-CARBOXAMIDE
3-(dimethylaminomethyl)-1,2,3,9-tetrahydro-4h-carbazole-4-one
tert-Butyl 4-(oxiran-2-ylmethyl)piperazine-1-carboxylate
tert-butyl N-(2-oxo-2-piperidin-1-ylethyl)carbamate
4-AMINOMETHYL-1-N-BUTYLPIPERIDINE 2HCL
C10H24Cl2N2 (242.13164439999997)
2-{5-[(1H-1,2,4-TR IAZOOL-1-YL)METHYL]INDOOL-3-YL}ETHAAN-1-OL
vinylmethylbis(methylethylketoximino)silane
C11H22N2O2Si (242.14504720000002)
1-TERT-BUTOXYCARBONYLPIPERIDINE-4-CARBOXYLICACIDMETHYLAMIDE
2-(3-AMINO-PROPYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
2-Azido-3-methylbutanoic acid - cyclohexanamine (1:1)
(8E,10E,12E)-heptadeca-8,10,12-trien-4,6-diyn-1-ol
6-(4-Tert-butylphenoxy)pyridin-3-amine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
1-(2-Ethoxyphenyl)piperazinium chloride
C12H19ClN2O (242.11858339999998)
(S)-3-ISOPROPYLAMINO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
Carbamic acid, N-[1-(2-aminoethyl)cyclohexyl]-, 1,1-dimethylethyl ester
2-BROMOMETHYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
tert-Butyl 4-((dimethylamino)methyl)piperidine-1-carboxylate
tert-butyl N-ethyl-N-(piperidin-4-ylmethyl)carbamate
[[[[3-(aminomethyl)phenyl]methyl]amino]methyl]phenol
7-(2-FURYLMETHYL)-5,6-DIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
tert-butyl N-[(4-ethylpiperidin-4-yl)methyl]carbamate
tert-butyl 4-(3-aminopropyl)piperidine-1-carboxylate
Phenol,4-chloro-2,6-bis[(dimethylamino)methyl]-
C12H19ClN2O (242.11858339999998)
1-(PIPERIDIN-4-YL)SPIRO[CYCLOPROPANE-1,3-INDOLIN]-2-ONE
1-(2-Methoxyphenyl)-tricyclo[3.3.1.13,7]decane 2-(Adamant-1-yl)methoxybenzene o-Adamantylanisole
2-(1,3-DIOXOLAN-2-ON-4-YL)-1-ETHYLBORONIC ACID PINACOL ESTER
C11H19BO5 (242.13254740000002)
2-(4-(TERT-BUTYL)PHENOXY)ACETIMIDAMIDE HYDROCHLORIDE
C12H19ClN2O (242.11858339999998)
(2,5-DIMETHOXY-BENZYL)-(2-METHOXY-1-METHYL-ETHYL)-AMINE
3-Trimethylsilyl-1-propylboronic acid pinacol ester, 94\\%
C12H27BO2Si (242.18732720000003)
tert-butyl 4-(2-amino-2-oxoethyl)piperidine-1-carboxylate
2,2-[5-(Hydroxymethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
3-[(2,5-DIMETHYLBENZYL)OXY]-6-METHYLPYRIDIN-2-AMINE
(3S,4E,6S)-1,3-Dihydroxy-6-isopropyl-3-methyl-4-decen-9-one
N,N-Diethyl-cyclohexane-1,4-diamine dihydrochloride
C10H24Cl2N2 (242.13164439999997)
tert-butyl ((3S,4S)-4-azidotetrahydro-2H-pyran-3-yl)carbamate
1-(2-BENZO[1,3]DIOXOL-5-YL-IMIDAZO[1,2-A]PYRIMIDIN-3-YLMETHYL)-PIPERIDINE-3-CARBOXYLICACID
4-[[tert-butyl(dimethyl)silyl]oxymethyl]cyclohexan-1-one
Morpholine,4,4-(1,3-dioxo-1,3-propanediyl)bis- (9CI)
TERT-BUTYL 3-OXOTETRAHYDRO-1H-OXAZOLO[3,4-A]PYRAZINE-7(3H)-CARBOXYLATE
5-(4-Chlorobutyl)-1-cyclohexyl-1H-tetrazole
C11H19ClN4 (242.12981639999998)
1,3-bis(3-aminopropyl)-5,5-dimethylimidazolidine-2,4-dione
4-N-(4,6-dimethylpyrimidin-2-yl)-4-N-ethylbenzene-1,4-diamine
(1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOL-5-YL)BORONIC ACID
C9H19BN2O3Si (242.12579340000002)
tert-butyl N-[(2S)-1-oxo-1-pyrrolidin-1-ylpropan-2-yl]carbamate
2-[(4,4-Diethoxy-2-butyn-1-yl)oxy]tetrahydro-2H-pyr
1-(5,6,7,7a,8,9,10,11-Octahydro-4H-benzo[ef]heptalen-2-yl)-ethanone
Monoethylglycinexylidide hydrochloride
C12H19ClN2O (242.11858339999998)
1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-8-methyl-2-(2-methylpropyl)-
CID 4369233
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease. (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE (±)-Huperzine A exhibited protective effects against d-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The (±)-Huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-κB nuclear localization and activation. (±)-Huperzine A is a potential therapeutic agent for Alzheimer's disease.
8-[(E)-3-hydroxybut-1-enyl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol
N-[(E)-Cyclohexylmethylideneamino]-1H-benzimidazol-2-amine
(5-Ethyl-8-methyl-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazine
(2E)-14-hydroxytetradec-2-enoic acid
An omega-hydroxy fatty acid that is trans-2-tetradecenoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.
(2E,13R)-13-hydroxytetradec-2-enoic acid
An (omega-1)-hydroxy fatty acid that is trans-2-tetradecenoic acid in which the 13-pro-R hydrogen is replaced by a hydroxy group.
2-Butyl-8-methyl-1,2,3,4-tetrahydro-gamma-carboline
2-sec-Butyl-8-methyl-1,2,3,4-tetrahydro-gamma-carboline
2,3,4,5-Tetrahydro-1,1,2,3,3-pentamethyl-1H-pyrido[4,3-b]indole
1,1,3,3,6-Pentamethyl-1,2,3,4-tetrahydro-gamma-carboline
1-Ethyl-2,3,4,5-tetrahydro-1,3,3-trimethyl-1H-pyrido[4,3-b]indole
3,4-Epoxy-4-(trimethylsilylmethyl)-1-cyclohexanecarboxylic acid methyl ester
C12H22O3Si (242.13381420000002)
3-oxotetradecanoic acid
A C14, long-chain fatty acid carrying an oxo- group at position 3.
(3R,4R)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one
A butan-4-olide that is gamma-butyrolactone with a 6-methylheptanoyl substituent at position 3 and a hydroxymethyl substituent at position 4 (the 3R,4R-stereoisomer).
Diphenylcarbazide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-hydroxy-1-methylbutyl)-
2-methyl-2-(4-methylpenta-1,3-dien-1-yl)chromen-6-ol
1-[5-(2-hydroxybutyl)furan-2-yl]-3-methoxybutan-2-ol
(5e,7s)-5-propylidene-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one
2-(5-methylhepta-1,3,5-trien-1-yl)-1h,1ah,2h,4h,5h,6h,7h,7bh-3λ⁵-cyclopropa[a]indolizin-3-ylium
[C17H24N]+ (242.19086439999998)
(6r,7s)-6-ethenyl-6-methyl-7-(prop-1-en-2-yl)-7,8-dihydro-5h-naphthalene-1,4-dione
4-(2,5-dihydroxycyclohexyl)-2-methylbut-2-en-1-yl acetate
7-amino-2,4-dimethyl-3h,4ah,5h,10bh-benzo[f]quinolin-6-one
(3r,4r,5s,6r)-4-hydroxy-6-[(1e)-3-hydroxy-3-methylpent-1-en-1-yl]-3,5-dimethyloxan-2-one
(3s,8as)-8a-hydroperoxy-1-hydroxy-3-(2-methylpropyl)-3h,6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
(1r,9r,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6-triene
(2e,8e,10e)-16-hydroxyhexadeca-2,8,10-trien-4,6-diynal
6-ethenyl-6-methyl-7-(prop-1-en-2-yl)-7,8-dihydro-5h-naphthalene-1,4-dione
(1s,9r,10r)-17-hydroxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,13-tetraen-17-ium
4-(1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one
13-acetoxy-9-tetradecene-2,4,6-triyne
{"Ingredient_id": "HBIN001122","Ingredient_name": "13-acetoxy-9-tetradecene-2,4,6-triyne","Alias": "NA","Ingredient_formula": "C16H18O2","Ingredient_Smile": "NA","Ingredient_weight": "242.31","OB_score": "NA","CAS_id": "6581-88-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9335","PubChem_id": "NA","DrugBank_id": "NA"}
2,5,6-trihydroxy-7-megastigmen-9-one
{"Ingredient_id": "HBIN004583","Ingredient_name": "2,5,6-trihydroxy-7-megastigmen-9-one","Alias": "NA","Ingredient_formula": "C13H22O4","Ingredient_Smile": "NA","Ingredient_weight": "242.31","OB_score": "NA","CAS_id": "135447-37-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8872","PubChem_id": "NA","DrugBank_id": "NA"}
2(e),9(z),16-heptadecatriene-4,6-diyne-8-ol
{"Ingredient_id": "HBIN005577","Ingredient_name": "2(e),9(z),16-heptadecatriene-4,6-diyne-8-ol","Alias": "NA","Ingredient_formula": "C17H22O","Ingredient_Smile": "CC=CC#CC#CC(C=CCCCCCC=C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9381","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
annuionone f
{"Ingredient_id": "HBIN016244","Ingredient_name": "annuionone f","Alias": "NA","Ingredient_formula": "C13H22O4","Ingredient_Smile": "CC1CC(=O)CC(C1(C=CC(C)O)O)(C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1337","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,8-dimethyl-7-(3-methylbut-2-en-1-yl)chromen-4-one
1-[(2r,5s,6r)-5-hydroxy-6-pentyloxan-2-yl]butan-2-one
(1s,3s,5s,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol
(3r,4s,5r)-4-hydroxy-4-[(1e,3r)-3-hydroxybut-1-en-1-yl]-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one
8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol
3,4,5-trimethyl-8-methylidene-5h,6h,7h-naphtho[2,3-b]furan-9-ol
(8r,9e,15z)-heptadeca-1,9,15-trien-11,13-diyn-8-ol
(8as,10ar)-5,8a-dimethyl-8,9,10,10a-tetrahydro-7h-anthracene-1,4-dione
(5s)-9-methoxy-3,4,5-trimethyl-5h,6h-naphtho[2,3-b]furan
(1s,2r,3r,5r,8r)-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-2,3-diol
9-methoxy-3,4,5-trimethyl-5h,6h-naphtho[2,3-b]furan
6,10-dimethyl-5,8,9,12-tetrahydrobenzo[10]annulene-1,4-dione
2-(2-hydroxypropan-2-yl)-4a-methyl-octahydro-1h-naphthalene-1,8-diol
3-[(2s,5s)-5-[(2s)-butan-2-yl]-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propanoic acid
1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
12-imino-n,n,2-trimethyl-4,6,11,13-tetraazatricyclo[8.3.0.0³,⁷]trideca-1,3,5,7,9-pentaen-5-amine
(13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
(8r,9e,15e)-heptadeca-1,9,15-trien-11,13-diyn-8-ol
(2s,3r)-1-[(1r,4r,5r,8s)-1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl]-3-hydroxy-2-methylbutan-1-one
(2r)-2-methyl-2-[(1e)-4-methylpenta-1,3-dien-1-yl]chromen-6-ol
(5s)-5-hydroxy-5-(7-hydroxy-6-methyloctyl)furan-2-one
(1r,9r,13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
(8z,10e,12e)-heptadeca-8,10,12-trien-4,6-diyn-1-ol
(1r,2r,5s)-2-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,3,3,5-tetramethylcyclohexane-1,2-diol
(5s)-3,4,5-trimethyl-8-methylidene-5h,6h,7h-naphtho[2,3-b]furan-9-ol
(2s,6s)-6-[(1e,3e,9e)-undeca-1,3,9-trien-5,7-diyn-1-yl]oxan-2-ol
4,8-dimethyltetracyclo[8.4.0.0³,⁸.0⁴,⁶]tetradeca-1(10),12-diene-11,14-dione
7-(2-hydroxyethyl)-2,2,7-trimethyl-hexahydro-1h-indene-4,5-diol
(5s)-5-(4,6-dihydroxy-6-methyloctyl)-5h-furan-2-one
dimethyl({[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl})amine
(6z,10e)-6,10-dimethyl-5,8,9,12-tetrahydrobenzo[10]annulene-1,4-dione
1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
8a-methyl-5-methylidene-6,7,8,9,10,10a-hexahydroanthracene-1,4-dione
4-hydroxy-4-(3-hydroxybut-1-en-1-yl)-3-(hydroxymethyl)-3,5-dimethylcyclohexan-1-one
(4r)-4-(hydroxymethyl)-3-(6-methylheptanoyl)oxolan-2-one
n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine
(5s)-5-(6,7-dihydroxy-6-methyloctyl)-5h-furan-2-one
(2e)-4-[(1r,2s,5r)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate
methyl 8-isopropyl-5-methylnaphthalene-2-carboxylate
(2e)-4-[(1r,2s,5s)-2,5-dihydroxycyclohexyl]-2-methylbut-2-en-1-yl acetate
(8ar,10ar)-8a-methyl-5-methylidene-6,7,8,9,10,10a-hexahydroanthracene-1,4-dione
(1r,9r,13r)-1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
1-{1,8-dimethyl-2,7-dioxabicyclo[3.2.1]octan-4-yl}-3-hydroxy-2-methylbutan-1-one
(8as,10as)-8a-methyl-5-methylidene-6,7,8,9,10,10a-hexahydroanthracene-1,4-dione
n-[7-methyl-12-(methylimino)-3,5,11,13-tetraazatricyclo[8.3.0.0²,⁶]trideca-1(10),2,6,8-tetraen-4-ylidene]methanamine
5,8a-dimethyl-8,9,10,10a-tetrahydro-7h-anthracene-1,4-dione
(1r,9s,13z)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol
(5s)-5-hydroxy-5-(6-hydroxy-6-methyloctyl)furan-2-one
(7e,9e,15e)-heptadeca-7,9,15-trien-11,13-diyn-1-ol
(2,3-dimethyl-6-oxooxan-4-yl)methyl 2-methylbutanoate
(4e,6e,12e)-tetradeca-4,6,12-trien-8,10-diyn-1-yl acetate
2-(3-methylbut-2-en-1-yl)-5-(3-methylbut-3-en-1-yn-1-yl)benzene-1,4-diol
(6z,10z)-6,10-dimethyl-5,8,9,12-tetrahydrobenzo[10]annulene-1,4-dione
n-[(2-aminophenyl)methyl]-2-(methoxymethyl)aniline
n-[2-methyl-12-(methylimino)-4,6,11,13-tetraazatricyclo[8.3.0.0³,⁷]trideca-1(10),2,6,8-tetraen-5-ylidene]methanamine
(8r,9z,15z)-heptadeca-1,9,15-trien-11,13-diyn-8-ol
(1r,2r,5s)-2-[(3r)-3-hydroxybut-1-en-1-yl]-1,3,3,5-tetramethylcyclohexane-1,2-diol
(6s,7r)-6-ethenyl-6-methyl-7-(prop-1-en-2-yl)-7,8-dihydro-5h-naphthalene-1,4-dione
(2s,3r)-1-[(3r,3ar,4s,5s,6ar)-4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl]-3-hydroxy-2-methylbutan-1-one
(e)-n-{2-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]ethylidene}hydroxylamine
(3e)-4-[(1r,3s,6r)-1,3,6-trihydroxy-2,2,6-trimethylcyclohexyl]but-3-en-2-one
8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octane-3,8-diol
(4as,9as)-3-isopropyl-9a-methyl-1,2,4a,9-tetrahydroxanthene
(1r,2r,4ar,8r,8as)-2-(2-hydroxypropan-2-yl)-4a-methyl-octahydro-1h-naphthalene-1,8-diol
(1r)-1-[(2s,5r)-5-(hydroxymethyl)oxolan-2-yl]-2-(pent-2-en-1-ylidene)propane-1,3-diol
1-{4,5-dimethyl-hexahydrofuro[2,3-b]furan-3-yl}-3-hydroxy-2-methylbutan-1-one
(4s,7e,9e,15e)-heptadeca-7,9,15-trien-11,13-diyn-4-ol
(7e,9e,13e,15e)-heptadeca-7,9,13,15-tetraen-11-ynal
(1ar,2s,7bs)-2-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-1h,1ah,2h,4h,5h,6h,7h,7bh-3λ⁵-cyclopropa[a]indolizin-3-ylium
[C17H24N]+ (242.19086439999998)